Intervention Protocol

You have free access to this content

HMG CoA reductase inhibitors (statins) for preventing acute kidney injury after surgical procedures requiring cardiac bypass

  1. Michelle Lewicki1,*,
  2. Irene Ng2,
  3. Antoine G Schneider1

Editorial Group: Cochrane Renal Group

Published Online: 30 APR 2013

DOI: 10.1002/14651858.CD010480


How to Cite

Lewicki M, Ng I, Schneider AG. HMG CoA reductase inhibitors (statins) for preventing acute kidney injury after surgical procedures requiring cardiac bypass (Protocol). Cochrane Database of Systematic Reviews 2013, Issue 4. Art. No.: CD010480. DOI: 10.1002/14651858.CD010480.

Author Information

  1. 1

    Monash University, Department of Epidemiology and Preventive Medicine, Melbourne, VIC, Australia

  2. 2

    Royal Melbourne Hospital, Department of Anaesthesia and Pain Management, Parkville, VIC, Australia

*Michelle Lewicki, Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, VIC, Australia. michellelewicki@me.com.

Publication History

  1. Publication Status: New
  2. Published Online: 30 APR 2013

SEARCH

References

Additional references

Arora 2008
  • Arora P, Rajagopalam S, Ranjan R, Kolli H, Singh M, Venuto R, et al. Preoperative use of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers is associated with increased risk for acute kidney injury after cardiovascular surgery. Clinical Journal of the American Society of Nephrology: CJASN 2008;3(5):1266-73. [MEDLINE: 18667735]
Asimakopoulos 2005
  • Asimakopoulos G, Karagounis AP, Valencia O, Alexander N, Howlader M, Sarsam MA, et al. Renal function after cardiac surgery off- versus on-pump coronary artery bypass: analysis using the Cockroft-Gault formula for estimating creatinine clearance. Annals of Thoracic Surgery 2005;79(6):2024-31. [MEDLINE: 15919303]
Baigent 2005
  • Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C, et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 2005;366(9493):1267-78. [MEDLINE: 16214597]
Bellomo 2004
  • Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P, Acute Dialysis Quality Initiative workgroup. Acute renal failure – definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Critical Care 2004;8(4):R204-212. [MEDLINE: 15312219]
Bove 2004
  • Bove T, Calabrò MG, Landoni G, Aletti G, Marino G, Crescenzi G, et al. The incidence and risk of acute renal failure after cardiac surgery. Journal of Cardiothoracic & Vascular Anesthesia 2004;18(4):442-5. [MEDLINE: 15365924]
Boyle 1997
  • Boyle EM Jr, Pohlman TH, Johnson MC, Verrier ED. Endothelial cell injury in cardiovascular surgery: the systemic inflammatory response. Annals of Thoracic Surgery 1997;63(1):277-84. [MEDLINE: 8993292]
Chawla 2012
  • Chawla LS, Zhao Y, Lough FC, Schroeder E, Seneff MG, Brennan JM. Off-pump versus on-pump coronary artery bypass grafting outcomes stratified by preoperative renal function. Journal of the American Society of Nephrology 2012;23(8):1389-97. [MEDLINE: 22595302]
Chello 2003
  • Chello M, Mastroroberto P, Patti G, D'Ambrosio A, Morichetti MC, Di Sciascio G, et al. Simvastatin attenuates leucocyte-endothelial interactions after coronary revascularisation with cardiopulmonary bypass. Heart 2003;89(5):538-43. [MEDLINE: 12695460]
Chertow 1997
  • Chertow GM, Lazarus JM, Christiansen CL, Cook EF, Hammermesiter KE, Grover F, et al. Preoperative renal risk stratification. Circulation 1997;95(4):878-84. [MEDLINE: 9054745]
Chukwuemeka 2005
  • Chukwuemeka A, Weisel A, Maganti M, Nette AF, Wijeysundera DN, Beattie WS, et al. Renal dysfunction in high-risk patients after on-pump and off-pump coronary artery bypass surgery: a propensity score analysis. Annals of Thoracic Surgery 2005;80(6):2148-53. [MEDLINE: 16305860]
Coca 2009
  • Coca SG, Yusuf B, Shlipak MG, Garg AX, Parikh CR. Long-term risk of mortality and other adverse outcomes after acute kidney injury: a systematic review and meta-analysis. American Journal of Kidney Diseases 2009;53(6):961-73. [MEDLINE: 19346042]
Conlon 1999
DerSimonian 1986
Devarajan 2006
Egger 1997
  • Egger M, Davey Smith G, Phillips AN. Meta-analysis: Principles and procedures. BMJ 1997;315(7121):1533-7. [MEDLINE: 9432252]
Endo 1976
Gueler 2002
  • Gueler F, Rong S, Park JK, Fiebeler A, Menne J, Elger M, et al. Postischemic acute renal failure is reduced by short-term statin treatment in a rat model. Journal of the American Society of Nephrology 2002;13(9):2288-98. [MEDLINE: 12191973]
Haslinger-Löffler 2008
Higgins 2003
Higgins 2011
  • Higgins JP, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
Inman 2005
  • Inman SR, Davis NA, Mazzone ME, Olson KM, Lukaszek VA, Yoder KN. Simvastatin and L-arginine preserve renal function after ischemia/reperfusion injury. American Journal of the Medical Sciences 2005;329(1):13-7. [MEDLINE: 15654174]
Jo 2008
  • Jo SH, Koo BK, Park JS, Kang HJ, Cho YS, Kim YJ, et al. Prevention of radiocontrast medium-induced nephropathy using short-term high-dose simvastatin in patients with renal insufficiency undergoing coronary angiography (PROMISS) trial--a randomized controlled study. American Heart Journal 2008;155(3):499, e1-8. [MEDLINE: 18294484]
Karkouti 2009
Lafrance 2010
Lamy 2012
  • Lamy A, Devereaux PJ, Prabhakaran D, Taggart DP, Hu S, Paolasso E, et al. Off-pump or on-pump coronary-artery bypass grafting at 30 days. New England Journal of Medicine 2012;366(16):1489-97. [MEDLINE: 22449296]
Li 2012
  • Li Y, Liu Y, Fu L, Mei C, Dai B. Efficacy of short-term high-dose statin in preventing contrast-induced nephropathy: a meta-analysis of seven randomized controlled trials. PLoS One 2012;7(4):e34450. [MEDLINE: 22511942]
Liakopoulos 2008
  • Liakopoulos OJ, Choi YH, Haldenwang PL, Strauch J, Wittwer T, Dörge H, et al. Impact of preoperative statin therapy on adverse postoperative outcomes in patients undergoing cardiac surgery: a meta-analysis of over 30,000 patients. European Heart Journal 2008;29(12):1548-59. [MEDLINE: 18506053]
Liakopoulos 2012
Mangano 1998
  • Mangano CM, Diamondstone LS, Ramsay JG, Aggarwal A, Herskowitz A, Mangano DT. Renal dysfunction after myocardial revascularization: risk factors, adverse outcomes, and hospital resource utilization. The Multicenter Study of Perioperative Ischemia Research Group. Annals of Internal Medicine 1998;128(3):194-203. [MEDLINE: 9454527]
Mariscalco 2011
Mehta 2007
Mistiaen 2009
  • Mistiaen W, Van Cauwelaert P, Muylaert P, De Worm E. A thousand pericardial valves in aortic position: risk factors for postoperative acute renal function impairment in elderly. Journal of Cardiovascular Surgery 2009;50(2):233-7. [MEDLINE: 18948862]
Ostermann 2000
Ozan 2010
  • Ozhan H, Erden I, Ordu S, Aydin M, Caglar O, Basar C, et al. Efficacy of short-term high-dose atorvastatin for prevention of contrast-induced nephropathy in patients undergoing coronary angiography. Angiology 2010;61(7):711-4.
Patti 2008
  • Patti G. Short-term high-dose atorvastatin for periprocedural myocardial infarction prevention in patients with renal dysfunction. Journal of Cardiovascular Medicine 2011;12(5):305-8. [MEDLINE: 21451331]
Srisawat 2010
  • Srisawat N, Lawsin L, Uchino S, Bellomo R, Kellum JA. Cost of acute renal replacement therapy in the intensive care unit: results from The Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) study. Critical Care 2010;14(2):R46. [MEDLINE: 20346163]
Sterne 2001
Swaminathan 2007
  • Swaminathan M, Shaw AD, Phillips-Bute BG, McGugan-Clark PL, Archer LE, Talbert S, et al. Trends in acute renal failure associated with coronary artery bypass graft surgery in the United States. Critical Care Medicine 2007;35(10):2286-91. [MEDLINE: 17944016]
Thakar 2003
Yokota 2003
  • Yokota N, O'Donnell M, Daniels F, Burne-Taney M, Keane W, Kasiske B, et al. Protective effect of HMG-CoA reductase inhibitor on experimental renal ischemia-reperfusion injury. American Journal of Nephrology 2003;23(1):13-7. [MEDLINE: 12373076]